These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 30062683

  • 1. Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.
    McCaughan JA, Tinckam KJ.
    Transpl Int; 2018 Oct; 31(10):1059-1070. PubMed ID: 30062683
    [Abstract] [Full Text] [Related]

  • 2. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M, Carroll RP, Tsiopelas E, Clayton P, Coates PT.
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [Abstract] [Full Text] [Related]

  • 3. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y, Ramon D, Luan FL, Sung R, Samaniego M.
    Clin Transpl; 2012 Jul; ():247-56. PubMed ID: 23721029
    [Abstract] [Full Text] [Related]

  • 4. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
    Caillard S, Becmeur C, Gautier-Vargas G, Olagne J, Muller C, Cognard N, Perrin P, Braun L, Heibel F, Lefebre F, Renner V, Gachet C, Moulin B, Parissiadis A.
    Transpl Int; 2017 Jan; 30(1):29-40. PubMed ID: 27678382
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 6. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.
    Abu-Elmagd KM, Wu G, Costa G, Lunz J, Martin L, Koritsky DA, Murase N, Irish W, Zeevi A.
    Am J Transplant; 2012 Nov 01; 12(11):3047-60. PubMed ID: 22947059
    [Abstract] [Full Text] [Related]

  • 7. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
    Perbos E, Juinier E, Guidicelli G, Dromer C, Merville P, Billes MA, Taupin JL, Neau-Cransac M.
    Clin Transplant; 2014 Sep 01; 28(9):1054-60. PubMed ID: 25040585
    [Abstract] [Full Text] [Related]

  • 8. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
    Abuhelaiqa E, Friedlander R, Aull M, Putheti P, Sharma V, Suthanthiran M, Dadhania D.
    Clin Transpl; 2016 Sep 01; 32():83-91. PubMed ID: 28564525
    [Abstract] [Full Text] [Related]

  • 9. From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.
    Lefaucheur C, Viglietti D, Mangiola M, Loupy A, Zeevi A.
    J Immunol Res; 2017 Sep 01; 2017():5201098. PubMed ID: 28133619
    [Abstract] [Full Text] [Related]

  • 10. Donor-Specific HLA Antibodies: A Review of Data Published in 2016.
    Idica A, Everly MJ.
    Clin Transpl; 2016 Sep 01; 32():13-22. PubMed ID: 28564519
    [Abstract] [Full Text] [Related]

  • 11. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ, Farr MA, Restaino SW, Zorn E, Latif F, Vasilescu ER, Marboe CC, Colombo PC, Mancini DM.
    J Heart Lung Transplant; 2017 May 01; 36(5):540-545. PubMed ID: 27916323
    [Abstract] [Full Text] [Related]

  • 12. Limited impact of pre-existing donor specific HLA-antibodies (DSA) on long term allograft survival after first adult liver transplantation.
    Koch M, Marget M, Sterneck M, Fischer L, Thude H, Nashan B.
    Hum Immunol; 2018 Jul 01; 79(7):545-549. PubMed ID: 29669260
    [Abstract] [Full Text] [Related]

  • 13. HLA antibodies are associated with deterioration of kidney allograft function irrespective of donor specificity.
    von Moos S, Cippà PE, van Breemen R, Mueller TF.
    Hum Immunol; 2021 Jan 01; 82(1):19-24. PubMed ID: 33162184
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.
    Transplantation; 2015 Jun 01; 99(6):1156-64. PubMed ID: 25629531
    [Abstract] [Full Text] [Related]

  • 15. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J.
    Nephrol Dial Transplant; 2016 Oct 01; 31(10):1738-45. PubMed ID: 27220757
    [Abstract] [Full Text] [Related]

  • 16. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY, Kaneku H, Farmer DG.
    Clin Transpl; 2014 Oct 01; ():153-9. PubMed ID: 26281140
    [Abstract] [Full Text] [Related]

  • 17. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 01; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 18. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov 01; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 19. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
    Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Hum Immunol; 2017 Sep 01; 78(9):526-533. PubMed ID: 28732720
    [Abstract] [Full Text] [Related]

  • 20. Clinical relevance of HLA antibody monitoring after kidney transplantation.
    Morath C, Opelz G, Zeier M, Süsal C.
    J Immunol Res; 2014 Sep 01; 2014():845040. PubMed ID: 25374891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.